United Neuroscience
unitedneuroscience.comVisual Preview
United Neuroscience (UNS) is a clinical-stage biotechnology company dedicated to developing innovative therapies for brain disorders, particularly Alzheimer's disease. The company focuses on active immunotherapeutics and vaccines that stimulate the production of endogenous antibodies, targeting harmful elements like beta-amyloid plaques. One of its key products is UB-311, a synthetic peptide vaccine aimed at treating mild Alzheimer's disease. This vaccine has shown safety and immunogenicity in clinical trials, with participants advancing to long-term studies to further assess its efficacy. United Neuroscience is committed to advancing its pipeline of vaccines and immunotherapeutics to improve brain health and address the challenges posed by neurodegenerative diseases.
Why follow United Neuroscience?
EarlyFinder highlights companies showing breakout signals across traffic, marketing activity, and revenue proxies. Create a free account to monitor performance, benchmark against peers, and export curated lists to your workflow.
Revenue & Pricing
Revenue insights
Revenue insights locked
Sign in to access estimates, confidence ratings, and revenue benchmarks.
Unlock insightsMonthly traffic trends
Website visits over the past 12 months
Website traffic locked
Sign in to view full trendlines, YoY growth, and segment performance.
Unlock insightsTop keywords
Organic opportunities driving discovery
Traffic sources
Channel mix across the latest month
Traffic sources locked
Sign in to view acquisition mix and paid vs. organic breakdowns.
Unlock insights